Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy

  • Veena Vijayan
  • Saji Uthaman
  • In-Kyu ParkEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1064)


Biomimetic nanoplatform being a recent and emerging strategy plays an important role in a wide variety of applications. The different types of membranes used for coating include membranes from red blood cells, platelets, leucocytes, neutrophils, cancer cells, stem cells, etc. The as obtained membrane vesicles are fused onto the core nanoparticles through extrusion, sonication, electroporation. Biomimetic nanoparticles attain special functions which include ligand recognition and targeting, long blood circulation, immune escaping, tumor targeting depending on the core-shell interactions. The membrane coated nanoparticles indeed mimic the source cells and improves the therapeutic efficacy of drugs other cargos through specific delivery and enhanced accumulation in the tumor.


Biomimetic Nanoparticles Ligand targeting Immune escape 


  1. Allouche J (2013) Synthesis of organic and bioorganic nanoparticles: an overview of the preparation methods. In: Nanomaterials: a danger or a promise? Springer, London, pp 27–74. CrossRefGoogle Scholar
  2. Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y (2016) Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 27;10(8):7738–7748. CrossRefGoogle Scholar
  3. Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fang RH, Zhang L (2017) A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release 264:102. CrossRefPubMedPubMedCentralGoogle Scholar
  4. Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, Gao G, Pan H, Liu L, Ma A, Cui H (2016) Cancer cell membrane–biomimetic nanoparticles for homologous-targeting dual-modal imaging and Photothermal therapy. ACS Nano 10(11):10049–10057. CrossRefPubMedPubMedCentralGoogle Scholar
  5. Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV, Gao W (2017) Erythrocyte–platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater 29(16):1606209. CrossRefGoogle Scholar
  6. Ding H, Lv Y, Ni D, Wang J, Tian Z, Wei W, Ma G (2015) Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer. Nanoscale 7(21):9806–9815. CrossRefPubMedPubMedCentralGoogle Scholar
  7. Fang RH, Hu CM, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L (2014) Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14(4):2181–2188. CrossRefPubMedPubMedCentralGoogle Scholar
  8. Fu Q, Lv P, Chen Z, Ni D, Zhang L, Yue H, Yue Z, Wei W, Ma G (2015) Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale 7(9):4020–4030. CrossRefPubMedPubMedCentralGoogle Scholar
  9. Gao W, Zhang L (2015) Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target 23(7–8):619–626. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q (2016) Stem cell membrane coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12(30):4056–4062. CrossRefPubMedPubMedCentralGoogle Scholar
  11. Gao L, Han L, Ding X, Xu J, Wang J, Zhu J, Lu W, Sun J, Yu L, Yan Z, Wang Y (2017a) An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles. Nanotechnology 28(33):335101. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Gao M, Liang C, Song X, Chen Q, Jin Q, Wang C, Liu Z (2017b) Erythrocyte membrane enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater 29(35). CrossRefGoogle Scholar
  13. He W, Frueh J, Wu Z, He Q (2016a) Leucocyte membrane-coated janus microcapsules for enhanced photothermal cancer treatment. Langmuir 32(15):3637–3644. CrossRefPubMedPubMedCentralGoogle Scholar
  14. He W, Frueh J, Wu Z, He Q (2016b) How leucocyte cell membrane modified janus microcapsules are phagocytosed by cancer cells. ACS Appl Mater Interfaces 8(7):4407–4415. CrossRefPubMedPubMedCentralGoogle Scholar
  15. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 108(27):10980–10985. CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hu CM, Fang RH, Copp J, Luk BT, Zhang L (2013) A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol 8(5):336–340. CrossRefPubMedPubMedCentralGoogle Scholar
  17. Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z (2015a) Anticancer platelet mimicking nanovehicles. Adv Mater 27(44):7043–7050. CrossRefPubMedPubMedCentralGoogle Scholar
  18. Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, Carpenter C (2015b) Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526(7571):118–121. CrossRefPubMedPubMedCentralGoogle Scholar
  19. Jiang X, Wang K, Zhou Z, Zhang Y, Sha H, Xu Q, Wu J, Wang J, Wu J, Hu Y, Liu B (2017a) Erythrocyte membrane nanoparticles improve the intestinal absorption of paclitaxel. Biochem Biophys Res Commun 488(2):322–328. CrossRefPubMedPubMedCentralGoogle Scholar
  20. Jiang Q, Luo Z, Men Y, Yang P, Peng H, Guo R, Tian Y, Pang Z, Yang W (2017b) Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. Biomaterials 143:29–45. CrossRefPubMedPubMedCentralGoogle Scholar
  21. Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Song Q, Wei X, Chen H, Gao X, Chen J (2017) Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano 11(2):1397–1411. CrossRefPubMedPubMedCentralGoogle Scholar
  22. Kroll AV, Fang RH, Zhang L (2016) Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug Chem 28(1):23–32. CrossRefPubMedPubMedCentralGoogle Scholar
  23. Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, Fu C, Li Y, Qu Q, Zhang Y, Ji S (2011) Silica nanorattle–doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5(9):7462–7470. CrossRefPubMedPubMedCentralGoogle Scholar
  24. Li J, Ai Y, Wang L, Bu P, Sharkey CC, Wu Q, Wun B, Roy S, Shen X, King MR (2016) Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials 76:52–65. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Li SY, Cheng H, Qiu WX, Zhang L, Wan SS, Zeng JY, Zhang XZ (2017a) Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials 142:149–161. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Li SY, Xie BR, Cheng H, Li CX, Zhang MK, Qiu WX, Liu WL, Wang XS, Zhang XZ (2017b) A biomimetic theranostic O2-meter for cancer targeted photodynamic therapy and phosphorescence imaging. Biomaterials 151:1. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Luk BT, Zhang L (2015) Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220:600–607. CrossRefPubMedPubMedCentralGoogle Scholar
  28. Luk BT, Hu CM, Fang RH, Dehaini D, Carpenter C, Gao W, Zhang L (2014) Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6(5):2730–2737. CrossRefPubMedPubMedCentralGoogle Scholar
  29. Luk BT, Fang RH, Hu CM, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L (2016) Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics 6(7):1004 Scholar
  30. Maher J, Davies ET (2004) Targeting cytotoxic T lymphocytes for cancer immunotherapy. Br J Cancer 91(5):817–821. CrossRefPubMedPubMedCentralGoogle Scholar
  31. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, Isenhart L (2013a) Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles. Nat Nanotechnol 8(1):61 Scholar
  32. Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, Isenhart L (2013b) Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8(1):61–68. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39–51. CrossRefPubMedPubMedCentralGoogle Scholar
  34. Rao L, Bu LL, Xu JH, Cai B, Yu GT, Yu X, He Z, Huang Q, Li A, Guo SS, Zhang WF (2015) Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance. Small 11(46):6225–6236. CrossRefPubMedPubMedCentralGoogle Scholar
  35. Rao L, Cai B, Bu LL, Liao QQ, Guo SS, Zhao XZ, Dong WF, Liu W (2017a) Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano 11:3496–3505. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Rao L, Meng QF, Bu LL, Cai B, Huang Q, Sun ZJ, Zhang WF, Li A, Guo SS, Liu W, Wang TH (2017b) Erythrocyte membrane coated Upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces 9(3):2159–2168. CrossRefPubMedPubMedCentralGoogle Scholar
  37. Rao L, He Z, Meng QF, Zhou Z, Bu LL, Guo SS, Liu W, Zhao XZ (2017c) Effective cancer targeting and imaging using macrophage membrane camouflaged upconversion nanoparticles. J Biomed Mater Res A 105(2):521–530. CrossRefPubMedPubMedCentralGoogle Scholar
  38. Ren X, Zheng R, Fang X, Wang X, Zhang X, Yang W, Sha X (2016) Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials 92:13–24. CrossRefPubMedPubMedCentralGoogle Scholar
  39. Ren H, Liu J, Li Y, Wang H, Ge S, Yuan A, Hu Y, Wu J (2017) Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Acta Biomater 59:269–282. CrossRefPubMedPubMedCentralGoogle Scholar
  40. Subcellular fractionation protocol, Abcam 2016Google Scholar
  41. Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W, Zhang P, Zhang Z, Yu H, Wang S, Li Y (2016) Cancer cell biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater 28(43):9581–9588. CrossRefPubMedPubMedCentralGoogle Scholar
  42. Suski JM, Lebiedzinska M, Wojtala A, Duszynski J, Giorgi C, Pinton P, Wieckowski MR (2014) Isolation of plasma membrane associated membranes from rat liver. Nat Protoc 9(2):312–322. CrossRefPubMedPubMedCentralGoogle Scholar
  43. Tan MC, Chow GM, Ren L, Zhang Q (2009) Inorganic nanoparticles for biomedical applications. InNanoSci Biomed:272–289 Springer, Berlin/Heidelberg. CrossRefGoogle Scholar
  44. Tan S, Wu T, Zhang D, Zhang Z (2015) Cell or Cell Membrane-Based Drug Delivery Systems. Theranostics 5(8):863–881CrossRefPubMedCentralGoogle Scholar
  45. Tian H, Luo Z, Liu L, Zheng M, Chen Z, Ma A, Liang R, Han Z, Lu C, Cai L (2017) Cancer cell membrane biomimetic oxygen Nanocarrier for breaking hypoxia induced Chemoresistance. Adv Funct Mater 27(38). CrossRefGoogle Scholar
  46. Treffers LW, Hiemstra IH, Kuijpers TW, Berg TK, Matlung HL (2016) Neutrophils in cancer. Immunol Rev 273(1):312–328. CrossRefPubMedPubMedCentralGoogle Scholar
  47. Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L (2016) Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials 111:116–123. CrossRefPubMedPubMedCentralGoogle Scholar
  48. Xuan M, Shao J, Dai L, Li J, He Q (2016) Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces 8(15):9610–9618. CrossRefPubMedPubMedCentralGoogle Scholar
  49. Zhang L, Li R, Chen H, Wei J, Qian H, Su S, Shao J, Wang L, Qian X, Liu B (2017a) Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomedicine 12:2129 Scholar
  50. Zhang Y, Zhang J, Chen W, Angsantikul P, Spiekermann KA, Fang RH, Gao W, Zhang L (2017b) Erythrocyte membrane coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release 263:185. CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zhu JY, Zheng DW, Zhang MK, Yu WY, Qiu WX, Hu JJ, Feng J, Zhang XZ (2016) Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett 16(9):5895–5901. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of Biomedical Sciences, BK21 PLUS Centre for Creative Biomedical ScientistsChonnam National University, Chonnam National University Medical SchoolGwangjuSouth Korea
  2. 2.Department of Polymer Science and EngineeringChungnam National UniversityDaejeonSouth Korea

Personalised recommendations